Boris Bloch to Sensitivity and Specificity
This is a "connection" page, showing publications Boris Bloch has written about Sensitivity and Specificity.
Connection Strength
0.257
-
Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, Susani M, Haitel A, Jaromi S, Ngo L, Rofsky NM. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. Radiology. 2007 Oct; 245(1):176-85.
Score: 0.057
-
Bloch BN, Helbich T, Heinz-Peer G. [Prostatic carcinoma: current status of diagnostic imaging]. Wien Med Wochenschr Suppl. 2002; (113):89-91.
Score: 0.039
-
Viswanath SE, Chirra PV, Yim MC, Rofsky NM, Purysko AS, Rosen MA, Bloch BN, Madabhushi A. Comparing radiomic classifiers and classifier ensembles for detection of peripheral zone prostate tumors on T2-weighted MRI: a multi-site study. BMC Med Imaging. 2019 02 28; 19(1):22.
Score: 0.032
-
Ginsburg SB, Viswanath SE, Bloch BN, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A. Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors. J Magn Reson Imaging. 2015 May; 41(5):1383-93.
Score: 0.023
-
Costa DN, Bloch BN, Yao DF, Sanda MG, Ngo L, Genega EM, Pedrosa I, DeWolf WC, Rofsky NM. Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. Magn Reson Imaging. 2013 Jul; 31(6):947-52.
Score: 0.021
-
Viswanath SE, Bloch NB, Chappelow JC, Toth R, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A. Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery. J Magn Reson Imaging. 2012 Jul; 36(1):213-24.
Score: 0.020
-
Keeling AN, Morrin MM, McKenzie C, Farrell RJ, Sheth SG, Ngo L, Bloch BN, Pedrosa I, Rofsky NM. Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: impact on colorectal polyp detection. Eur J Radiol. 2012 Jan; 81(1):31-8.
Score: 0.018
-
Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer. Invest Radiol. 2010 Apr; 45(4):174-81.
Score: 0.017
-
Morrin MM, Pedrosa I, McKenzie CA, Farrell RJ, Bloch N, Solazzo S, Ngo L, Goldberg SN, Rofsky NM. Parallel imaging enhanced MR colonography using a phantom model. J Magn Reson Imaging. 2008 Sep; 28(3):664-72.
Score: 0.015
-
Viswanath S, Bloch BN, Genega E, Rofsky N, Lenkinski R, Chappelow J, Toth R, Madabhushi A. A comprehensive segmentation, registration, and cancer detection scheme on 3 Tesla in vivo prostate DCE-MRI. Med Image Comput Comput Assist Interv. 2008; 11(Pt 1):662-9.
Score: 0.015